Eagleton, Matthew J <br/><br/>
Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology.  [electronic resource] 

 -  Vascular   
 - 171-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1708-5381 
<br/><br/><label>Standard No.: </label>10.2310/6670.2008.00030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Atherosclerosis--chemically induced<br/>Calcium Channel Blockers--therapeutic use<br/>Chronic Disease<br/>Female<br/>Humans<br/>Hypolipidemic Agents--therapeutic use<br/>Lower Extremity--blood supply<br/>Male<br/>Middle Aged<br/>Peripheral Vascular Diseases--chemically induced<br/>Prospective Studies<br/>Ultrasonography, Interventional--methods